Researched profile. The figures here are modelled by us from public information, published with the sources they were drawn from. How we research.
Nobody has priced this business, and this is not a price for the company. It is a model — a 2.6 base multiple moved by what the public record supports — applied to trailing-twelve modelled profit on the Amazon listings alone.
Indicative valuation: $397,319,107 — 5.25× a trailing-twelve net profit of $75,679,830, scored as of Sep 2026. Trailing-twelve modelled net profit at a modelled multiple. The Amazon listings only — other sellers’ sales on them included — and not the company.
The positives are durability and depth: twelve years of listings, a seller record at 99% over tens of thousands of ratings, reviews in the top band and revenue spread across the year rather than piled into one season. The model has no factor for what most weakens the figure — the reseller share of the listings — so the multiple is only as good as the profit under it.
Four answers are inferences rather than reads. Sourcing, catalogue shape and the differentiation level are questionnaire answers taken here from the public record, and the differentiation call alone is worth 0.55 of the multiple: a liquid, organic formulation is a real change of form, but a supplement is also something a contract manufacturer can approximate. The rating of 4.5 sits exactly on a band boundary. Brand Registry is firmer — Amazon gates the brand store behind enrolment. All of these are the first things to put to the owner.